CGON
Price
$37.58
Change
+$1.10 (+3.02%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
2.78B
53 days until earnings call
CRIS
Price
$1.67
Change
+$0.03 (+1.83%)
Updated
Sep 26, 04:59 PM (EDT)
Capitalization
20.5M
Interact to see
Advertisement

CGON vs CRIS

Header iconCGON vs CRIS Comparison
Open Charts CGON vs CRISBanner chart's image
CG Oncology
Price$37.58
Change+$1.10 (+3.02%)
Volume$13.5K
Capitalization2.78B
Curis
Price$1.67
Change+$0.03 (+1.83%)
Volume$2.47K
Capitalization20.5M
CGON vs CRIS Comparison Chart in %
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. CRIS commentary
Sep 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a StrongBuy and CRIS is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 27, 2025
Stock price -- (CGON: $36.48 vs. CRIS: $1.64)
Brand notoriety: CGON and CRIS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 54% vs. CRIS: 125%
Market capitalization -- CGON: $2.78B vs. CRIS: $20.5M
CGON [@Biotechnology] is valued at $2.78B. CRIS’s [@Biotechnology] market capitalization is $20.5M. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileCRIS’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • CRIS’s FA Score: 0 green, 5 red.
According to our system of comparison, CGON is a better buy in the long-term than CRIS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 6 TA indicator(s) are bullish while CRIS’s TA Score has 3 bullish TA indicator(s).

  • CGON’s TA Score: 6 bullish, 4 bearish.
  • CRIS’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, CGON is a better buy in the short-term than CRIS.

Price Growth

CGON (@Biotechnology) experienced а -6.03% price change this week, while CRIS (@Biotechnology) price change was -4.65% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +9.02%, and the average quarterly price growth was +51.46%.

Reported Earning Dates

CGON is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($2.78B) has a higher market cap than CRIS($20.5M). CGON YTD gains are higher at: 27.197 vs. CRIS (-46.405). CRIS has higher annual earnings (EBITDA): -36.02M vs. CGON (-157.09M). CGON has more cash in the bank: 661M vs. CRIS (10.1M). CGON has less debt than CRIS: CGON (994K) vs CRIS (2.31M). CRIS has higher revenues than CGON: CRIS (11.4M) vs CGON (551K).
CGONCRISCGON / CRIS
Capitalization2.78B20.5M13,571%
EBITDA-157.09M-36.02M436%
Gain YTD27.197-46.405-59%
P/E RatioN/AN/A-
Revenue551K11.4M5%
Total Cash661M10.1M6,545%
Total Debt994K2.31M43%
FUNDAMENTALS RATINGS
CRIS: Fundamental Ratings
CRIS
OUTLOOK RATING
1..100
60
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
65

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGONCRIS
RSI
ODDS (%)
Bearish Trend 2 days ago
75%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bullish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
76%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 9 days ago
74%
Bullish Trend 18 days ago
75%
Declines
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
83%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRIS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ACAZX48.19N/A
N/A
Alger Capital Appreciation Z
GMEPX28.68N/A
N/A
Goldman Sachs China Equity P
SNTFX21.47N/A
N/A
Steward Values Enhanced International R6
HDGVX37.84N/A
N/A
Hartford Dividend and Growth R6
EPSIX25.09-0.15
-0.59%
NYLI Epoch Global Equity Yield Inv Class

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with SYRE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
-0.55%
SYRE - CGON
59%
Loosely correlated
-8.18%
IDYA - CGON
58%
Loosely correlated
+0.08%
XNCR - CGON
56%
Loosely correlated
-1.34%
ACLX - CGON
56%
Loosely correlated
-0.44%
CRNX - CGON
55%
Loosely correlated
+2.02%
More

CRIS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRIS has been loosely correlated with ABEO. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if CRIS jumps, then ABEO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRIS
1D Price
Change %
CRIS100%
-2.96%
ABEO - CRIS
37%
Loosely correlated
-3.42%
VTGN - CRIS
37%
Loosely correlated
-2.88%
CGON - CRIS
35%
Loosely correlated
-0.55%
ROIV - CRIS
35%
Loosely correlated
+1.77%
OBIO - CRIS
34%
Loosely correlated
+0.41%
More